Ads
related to: how to dose insulin inpatient practice treatment options- Are You Covered?
Free benefits check
through our form.
- What Is Omnipod®?
A wearable and waterproof
insulin delivery system.
- Omnipod® 5 System
Integrates with Dexcom G6 to
simplify life® with diabetes.
- Podder Reviews
Hear how Omnipod® has simplified
life for others.
- Are You Covered?
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Intensive insulin therapy or flexible insulin therapy is a therapeutic regimen for diabetes mellitus treatment. This newer approach contrasts with conventional insulin therapy. Rather than minimize the number of insulin injections per day (a technique which demands a rigid schedule for food and activities), the intensive approach favors ...
In 1927, Sakel, who had recently qualified as a medical doctor in Vienna and was working in a psychiatric clinic in Berlin, began to use low (sub-coma) doses of insulin to treat drug addicts and psychopaths, and when one of the patients experienced improved mental clarity after having slipped into an accidental coma, Sakel reasoned the treatment might work for mentally ill patients. [3]
Insulin resistance, or low insulin sensitivity, happens when cells throughout the body don’t respond properly to the hormone insulin, especially cells in muscles, fat and the liver.
Prandial insulin, also called mealtime or bolus insulin, is designed as a bolus dose of insulin prior to a meal to regulate the spike in blood glucose that occurs following a meal. The dose of prandial insulin may be static, or may be calculated by the patient using either their current blood sugar, planned carbohydrate intake, or both.
Insulin glargine/lixisenatide, marketed under the brand name Soliqua, [168] is a fixed-dose combination medication that combines insulin glargine and lixisenatide for the treatment of diabetes. [169] The most common side effects include (hypoglycemia, diarrhea, vomiting, and nausea. [168]
A Cochrane systematic review from 2011 showed that treatment with Sulfonylureas did not improve control of glucose levels more than insulin at 3 nor 12 months of treatment. [28] This same review actually found evidence that treatment with Sulfonylureas could lead to earlier insulin dependence, with 30% of cases requiring insulin at 2 years. [ 28 ]
Ads
related to: how to dose insulin inpatient practice treatment options